Amrubicin CAS:110267-81-7, a potent anthracycline, effectively treats various cancers. This synthetic drug exhibits strong antitumor activity. It targets topoisomerase II, disrupting DNA replication. Amrubicin demonstrates fewer cardiotoxic effects compared to doxorubicin. The drug metabolizes into amrubicinol, increasing its efficacy. Administered intravenously, amrubicin is used for small cell lung cancer and relapsed aggressive non-Hodgkin lymphomas. Research on other malignancies continues.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.